Paris, France and Camberley, UK – 2 January 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is further summarised
Visit PageCategory: Products
Novacyt Trading Update
Novacyt trading update Paris, France and Camberley, UK – 24 December 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics products, on the 11 December announced its decision to sell the NOVAprep® business unit. As a result, the Company confirms that NOVAprep® will be treated as a discontinued operation under
Visit PageNovacyt launches two new CE-IVD Marked molecular diagnostic kits
Novacyt launches two new molecular CE Mark assays First of an expanding menu of tests for monitoring post-transplantation and immunosuppressed patients
Visit Page